Characterization and Cloning of a 58/53-kDa Substrate of the Insulin Receptor Tyrosine Kinase
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
A monoclonal antibody has been produced which immunoprecipitates 58- and 53-kDa proteins which are rapidly tyrosine phosphorylated in insulin-treated cells. These proteins can also be tyrosine phosphorylated in vitro by the isolated human insulin receptor. Increased tyrosine phosphorylation of these proteins is also observed in cells expressing a transforming chicken c-Src (mutant Phe-527) and in cells with the activated tyrosine kinase domains of the Drosophila insulin receptor, human insulin-like growth factor I receptor, and human insulin receptor-related receptor. P58/53 did not appear to associate with either the GTPase activating protein of Ras (called GAP) or the phosphatidylinositol 3-kinase by either co-immunoprecipitation experiments or in Far Westerns with the SH2 domains of these two proteins. Since p58/53 did not appear, by immunoblotting, to be related to any previously described tyrosine kinase substrate such as the SH2 containing proteins SHC and the tyrosine phosphatase Syp, the protein was purified in sufficient amounts to obtain peptide sequence. This sequence was utilized to isolate a cDNA clone that encodes a previously uncharacterized 53-kDa protein which, when expressed in mammalian cells, is tyrosine phosphorylated by the insulin receptor.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Protein modules and signalling networks
Pawson, T. (1995) · Nature · doi:10.1038/373573a0 · Cited by 2,420
Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene
Araki, E., Lipes, M. A., Patti, M.-E., Brüning, J. C., Haag III, B., Johnson, R. S., & Kahn, C. R. (1994) · Nature · doi:10.1038/372186a0 · Cited by 1,252
Ellis, L., Clauser, E., Morgan, D. O., Edery, M., Roth, R. A., & Rutter, W. J. (1986) · Cell · doi:10.1016/0092-8674(86)90786-5 · Cited by 1,070
Self-citation
Cited by
The WASP-WAVE protein network: Connecting the membrane to the cytoskeleton.
Takenawa, T., & Suetsugu, S. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2069 · Cited by 947
Takenawa, T., & Miki, H. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.10.1801 · Cited by 604
Dendritic mRNA: transport, translation and function
Bramham, C. R., & Wells, D. G. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2150 · Cited by 579
IRSp53 is an essential intermediate between Rac and WAVE in the regulation of membrane ruffling
Miki, H., Yamaguchi, H., Suetsugu, S., & Takenawa, T. (2000) · Nature · doi:10.1038/35047107 · Cited by 557
Cdc42 induces filopodia by promoting the formation of an IRSp53:Mena complex
Krugmann, S., Jordens, I., Gevaert, K., Driessens, M., Vandekerckhove, J., & Hall, A. (2001) · Current Biology · doi:10.1016/s0960-9822(01)00506-1 · Cited by 420
Identification of Proteins in the Postsynaptic Density Fraction by Mass Spectrometry
Walikonis, R. S., Jensen, O. N., Mann, M., Provance, D. W., Mercer, J. A., & Kennedy, M. B. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-11-04069.2000 · Cited by 397
Abbott, M.-A., Wells, D. G., & Fallon, J. R. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-17-07300.1999 · Cited by 327
Filopodia-based Wnt transport during vertebrate tissue patterning
Stanganello, E., Hagemann, A. I. H., Mattes, B., Sinner, C., Meyen, D., Weber, S., Schug, A., Raz, E., & Scholpp, S. (2015) · Nature Communications · doi:10.1038/ncomms6846 · Cited by 256
Structural basis of filopodia formation induced by the IRSp53/MIM homology domain of human IRSp53
Millard, T. H., Bompard, G., Heung, M. Y., Dafforn, T. R., Scott, D. J., Machesky, L. M., & Fütterer, K. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600535 · Cited by 232
“An actin regulator that has attracted a great deal of attention recently is the ‘insulin receptor tyrosine kinase substrate p53’ (IRSp53), also known as ‘brain-specific angio- genesis inhibitor 1 associated protein 2’ (BAIAP2) (Yeh et al, 1996).”
BackgroundI-BAR domain proteins: linking actin and plasma membrane dynamics
Zhao, H., Pykäläinen, A., & Lappalainen, P. (2011) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2010.10.005 · Cited by 208
“This protein was originally identified in a screen for substrates of insulin and insulin-like growth factor 1 [35].”
BackgroundYoshimura, Y., Shinkawa, T., Taoka, M., Kobayashi, K., Isobe, T., & Yamauchi, T. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.6320 · Cited by 94
The neuronal insulin receptor in its environment
Gralle, M. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.13909 · Cited by 64
Insulin, Synaptic Function, and Opportunities for Neuroprotection
Mielke, J. G., & Wang, Y.-T. (2011) · Progress in Molecular Biology and Translational Science · doi:10.1016/b978-0-12-385506-0.00004-1 · Cited by 55
The Role of WAVE2 Signaling in Cancer
Rana, P. S., Alkrekshi, A., Wang, W., Markovic, V., & Sossey-Alaoui, K. (2021) · Biomedicines · doi:10.3390/biomedicines9091217 · Cited by 25
“Suppression of BRK1 as a result of miR-181c overexpression has been known to reduce protein expression of WAVE2 complex (WAVE2, ABI1, SRA1 and HEM1) in HeLa [80], osteosarcoma U2OS cell lines, Jurkat and primary T cells [118–120].”
Background
Metadata
- Authors
- Yeh, T. C., Ogawa, W., Danielsen, A. G., & Roth, R. A.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1996-02
- Volume
- 271
- Issue
- 6
- Pages
- 2921-2928
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2024330189
- Cited by
- 97
- References
- 3
- FWCI
- 1.98
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.